Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001013762-23-001295

Chief Scientific Officer acquired 2,569,458 shares (conversion)

  • Chief Scientific Officer returned 2,569,458 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Owned after D/I
2023-10-01 Conversion : show line 1 in the form +2,527,477 3,027,483 I
2023-10-01 Returned to the company : show line 2 in the form −2,527,477 0 I
2023-10-01 Conversion : show line 3 in the form +41,981 140,071 D
2023-10-01 Returned to the company : show line 4 in the form −41,981 196,316 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-10-01 Conversion : show line 5 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG −75,136 0 I
2023-10-01 Conversion : show line 6 in the form Common shares, par value CHF 0.10 per share, of MoonLake AG −1,248 5,836 D
Loading xslF345X05/ownership.xml…